RxDoctor Payments Data

Jamie McFarland, APRN

Psychiatric/Mental Health · Covington, TNNPI 1336770015

Payments from drug & device makers

$498in general payments, 2019–2025

Across 25 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$138
  • AbbVie$114
  • Otsuka America Pharmaceutical, Inc.$61
  • Alnylam Pharmaceuticals Inc.$42
  • Teva Pharmaceuticals USA, Inc.$36
  • Neurocrine Biosciences, Inc.$21
  • plus $86 from 5 others

What the payments were for

  • Food & beverage$44990%
  • Education$4910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$498 in reported general payments places this provider in the 40th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$16,121
Medicare patients
19
Services billed
242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl34$49,778
Invega SustennaPaliperidone Palmitate14$39,058
Fluoxetine Hcl22$1,691
Aripiprazole30$1,155
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine43$1,066
Buspirone Hcl43$627
Duloxetine Hcl37$623
Trazodone Hcl49$564
Bupropion Hcl SrBupropion Hcl27$454
Quetiapine Fumarate16$429
Bupropion XlBupropion Hcl22$412
Ziprasidone Hcl14$397
Escitalopram Oxalate25$381
Lamotrigine44$327
Olanzapine30$244

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$114$49,77834 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Covington

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →